Two clinical trials of gold nanocrystals at University of Texas Southwestern Medical Center resulted in “significantly reversed deficits of metabolites linked to energy activity in the brain and resulted in functional improvements” in patients with multiple sclerosis (MS) and Parkinson’s disease, the medical center said in a Feb. 13 news announcement. While these trials focused…